Skip to content
OpenCapital
Get started

BioCardia, Inc. BCDA Q4 2025 Annual earnings

Reported March 24, 2026 · After market close

Diluted EPS-$0.06Beat by $0.14
Revenue estimate$25.0K
EPS estimate-$0.20

Next report

Aug 10, 2026 (In 4 weeks)
EPS estimate-$0.19

Versus estimates

Revenue

Q4 2024$25.0KBeat by $2.5K

Diluted EPS

Q1 2026-$0.21Miss by $0.04
Q4 2025-$0.06Beat by $0.14
Q3 2025-$0.24Beat by $0.01Q2 2025-$0.40Miss by $0.15Q1 2025-$0.59Miss by $0.20Q4 2024-$0.25Beat by $0.62

Ask the moment BioCardia, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioCardia, Inc. report Q4 2025 earnings?
BioCardia, Inc. (BCDA) reported Q4 2025 earnings on March 24, 2026 after market close.
What were BioCardia, Inc.'s Q4 2025 revenue and EPS?
BioCardia, Inc. reported diluted EPS of $-0.06 for Q4 2025.
Did BioCardia, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.20 by $0.14.
How did BioCardia, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 76.0% from $-0.25.
Where can I find BioCardia, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001437749-26-009609) and the 10-K periodic report (0001437749-26-009587) directly on SEC EDGAR. The filing index links above go to sec.gov.